Adela: Funding, Investors & Team (Oct 2026)
Adela specializes in creating groundbreaking and easily accessible technologies that aim to identify cancer and other diseases with high rates of illness and death. Through a simple blood test, Adela's advanced technology, known as the genome-wide methylome enrichment platform, efficiently collects data from the entire methylome. This innovative system accurately differentiates between the most informative (methylated) parts of the genome and non-informative sections, giving priority to sequencing those valuable regions.
Adela has raised $81.0M across 3 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Apr 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Adela Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Adela Funding Rounds
Adela raised $28.0M in an undisclosed round announced in Aug 2023.
1 month later, a Series A of $48.0M was announced in Sep 2023.
2.6 years later, an undisclosed round of $5.0M was announced in Apr 2026.
Adela Founders and Leadership Team
Contact details for the Adela team: 1 of 2 have an email address on file.
Start 14-day free trial →Adela Funding Compared to Other Biotechnology Startups
Adela's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Adela in Biotechnology and Foster City
Companies Similar to Adela
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Adela Funding FAQs
What does Adela do?
Adela specializes in creating groundbreaking and easily accessible technologies that aim to identify cancer and other diseases with high rates of illness and death. Through a simple blood test, Adela's advanced technology, known as the genome-wide methylome enrichment platform, efficiently collects data from the entire methylome. This innovative system accurately differentiates between the most informative (methylated) parts of the genome and non-informative sections, giving priority to sequencing those valuable regions.
How much funding has Adela raised?
Adela has raised $81.0M across 3 rounds on record. The most recent is an undisclosed round of $5.0M announced in Apr 2026.
When did Adela last raise funding?
Adela's most recent funding round on record is an undisclosed round of $5.0M, announced in Apr 2026.
Who founded Adela?
FundedIQ lists Lisa Alderson (Founder) at Adela.
Who is the CEO of Adela?
Scott Bratman is listed as CEO at Adela.
Where is Adela headquartered?
Adela is based in Foster City, California, United States.
How many employees does Adela have?
Adela is in the 51-100 employee band.
How does Adela's funding compare to other Biotechnology startups?
Adela's latest round of $5.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Adela Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Adela is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.